Riskpilot← Back to searchSign inGet full accessVIVUS AS
ASActiveOrg 930149055Storgata 2, 3510 HønefossGeneral medical practice activities · NACE 8621Est. 20224 employees
Revenue 2024
NOK 1,3M
-57% vs 2023
EBITDA margin
-8.8%
-129% vs 2023
Equity ratio
65.7%
Financial strength
Net profit 2024
NOK -139K
-141% vs 2023
| Revenue | NOK 1,3M | -57% |
| EBITDA | NOK -118K | -129% |
| Net profit | NOK -139K | -141% |
| Total assets | NOK 96K | -81% |
| Equity | NOK 63K | -69% |
| Employees | 4 | — |
Legal name
VIVUS AS
Org number
930149055
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. november 2022
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Daglig leder eller styrets leder alene.
Company purpose
Salg av lege og helsetjenester.
Address
Storgata 2, 3510 Hønefoss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 3 142 | 1 346 |
| Staff expenses | −8 | −405 | −125 |
| EBITDA | −142 | 406 | −118 |
| Depreciation & amort. | −0 | −16 | −27 |
| EBIT | −142 | 390 | −145 |
| Net financials | −5 | −3 | 3 |
| Profit before tax | −148 | 386 | −142 |
| Tax | −0 | 50 | −3 |
| Net profit | −148 | 336 | −139 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 81 | 515 | 96 |
| Equity | −133 | 203 | 63 |
| Long-term debt | 140 | 3 | 0 |
| Short-term debt | 75 | 309 | 33 |
| Total debt | 215 | 312 | 33 |
EBITDA margin
-8.8%
This company
15.8%
Market median
-156% vs market
20222024
Equity ratio
65.7%
This company
38.2%
Market median
+72% vs market
20222024
Return on equity
-219.6%
This company
18.4%
Market median
-1293% vs market
20222024
Net profit margin
-10.4%
This company
8.1%
Market median
-228% vs market
20222024
Asset turnover
13.95×
This company
1.12×
Market median
+1146% vs market
20222024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20222024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2022-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Chairman | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Tiurtoppen As | Company | 33.3% | 33.3% | 2023 |
Guttormsen Holding As | Company | 33.3% | 33.3% | 2023 |
Novia Holding As | Company | 33.3% | 33.3% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Guttormsen Holding As
VIVUS AS Board members of VIVUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Gotteberg Christensen | Board of Directors | 0 companies |
| Andreas Wiik Fosmo | Board of Directors | 0 companies |
| Sølvi Karin Hole | Deputy Chairman | 0 companies |
| Ole Kristoffer Hole Olsen | Chairman | 0 companies |
| Marianne Feldt Olsen | Board of Directors | 0 companies |
| Rune Olsen | Board of Directors | 0 companies |
| Gaute Johnsrud Guttormsen | Chairman | 0 companies |